ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Down 48.4% in November

ASP Isotopes Inc. (NASDAQ:ASPI) was the target of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 5,570,000 shares, a drop of 48.4% from the October 31st total of 10,800,000 shares. Based on an average trading volume of 4,050,000 shares, the short-interest ratio is currently 1.4 days. Approximately 12.3% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ASPI. Canaccord Genuity Group reaffirmed a “buy” rating and set a $4.50 price objective on shares of ASP Isotopes in a research note on Friday, October 18th. Canaccord Genuity Group initiated coverage on ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock. Finally, HC Wainwright dropped their price objective on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a report on Wednesday, August 7th.

Hedge Funds Weigh In On ASP Isotopes

A number of institutional investors have recently bought and sold shares of the stock. The Manufacturers Life Insurance Company purchased a new position in shares of ASP Isotopes during the 3rd quarter worth approximately $52,000. Fielder Capital Group LLC bought a new stake in shares of ASP Isotopes during the second quarter valued at approximately $55,000. KKM Financial LLC grew its stake in ASP Isotopes by 66.2% in the third quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock worth $63,000 after purchasing an additional 9,000 shares during the period. Sanctuary Advisors LLC bought a new position in ASP Isotopes in the third quarter worth $66,000. Finally, MetLife Investment Management LLC purchased a new position in ASP Isotopes during the third quarter valued at $88,000. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Trading Up 10.6 %

NASDAQ ASPI traded up $0.53 during trading on Friday, hitting $5.55. The company had a trading volume of 3,833,717 shares, compared to its average volume of 1,796,681. The company’s fifty day moving average is $5.21 and its 200-day moving average is $3.92. ASP Isotopes has a one year low of $1.65 and a one year high of $9.33. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The company has a market cap of $396.21 million, a price-to-earnings ratio of -8.87 and a beta of 3.88.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.